New Zealand markets open in 4 hours 56 minutes

Genmab A/S (GMAB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
35.52+0.39 (+1.11%)
As of 01:03PM EDT. Market open.
Show:
Annual

Income statement

Currency in DKK. All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
9,020,000
8,482,000
10,111,000
5,366,000
3,025,137
Operating expenses
Research development
4,486,000
4,181,000
3,137,000
2,386,000
1,431,159
Selling general and administrative
1,534,000
1,283,000
661,000
342,000
213,695
Total operating expenses
6,020,000
5,464,000
3,798,000
2,728,000
1,644,854
Operating income or loss
3,000,000
3,018,000
6,313,000
2,638,000
1,380,283
Interest expense
14,000
13,000
10,000
14,000
417
Total other income/expenses net
14,000
781,000
-583,000
108,000
169,183
Income before tax
3,171,000
3,983,000
5,904,000
2,859,000
1,611,971
Income tax expense
794,000
975,000
1,146,000
693,000
139,830
Income from continuing operations
2,377,000
3,008,000
4,758,000
2,166,000
1,472,141
Net income
2,377,000
3,008,000
4,758,000
2,166,000
1,472,141
Net income available to common shareholders
2,377,000
3,008,000
4,758,000
2,166,000
1,472,141
Basic EPS
-
4.60
7.30
3.44
2.40
Diluted EPS
-
4.55
7.22
3.40
2.37
Basic average shares
-
656,343
651,790
629,628
612,680
Diluted average shares
-
660,458
658,859
636,368
620,450
EBITDA
-
4,244,000
6,173,000
3,012,000
1,699,985